Betadex Sulfobutyl Ether Sodium Advanced Solubilizer and Stabilizer for Drug Formulation
Xi'an Deli Biochemical Industry Co.,Ltd. Is a high-tech enterprise specializing in research & development, production & sales of cyclodextrin and its derivatives.
Since its establishment on August 27, 1999,the company has been adhering to the quality Policy of "focusing on accessories, quality first, sincere service, striving for first-class". After more than 20 years of hard work and development, the company currently has products DELI Brand Hydroxypropyl Betadex 128446-35-5. The above products have been registered and filed with the FDA.
Betadex Sulfobutyl Ether Sodium Advanced Solubilizer and Stabilizer for Drug Formulation
Betadex Sulfobutyl Ether Sodium (SBE-β-CD, CAS 182410-00-0) is an advanced excipient that enhances solubility, stability, and bioavailability of poorly soluble drugs. Ideal for injectables, oral and ophthalmic formulations, it ensures safe, effective, and reliable drug delivery.
Betadex Sulfobutyl Ether Sodium (SBE-β-CD), CAS 182410-00-0, is an advanced cyclodextrin derivative widely recognized for its exceptional ability to enhance the solubility, stability, and bioavailability of poorly soluble drug molecules. With its unique sulfobutyl ether substitution, SBE-β-CD exhibits excellent safety, high aqueous solubility, and strong inclusion complex formation properties, making it an ideal excipient in modern pharmaceutical formulations.
This versatile excipient is commonly applied in injectable, oral, and ophthalmic drug delivery systems, where improved dissolution rate and controlled release are critical. It helps reduce drug irritation, masks unpleasant taste, and ensures consistent therapeutic performance. SBE-β-CD is manufactured under strict quality standards and complies with international pharmacopeial guidelines, ensuring reliability for both research and large-scale production. With proven performance and broad compatibility, Betadex Sulfobutyl Ether Sodium is a trusted choice for pharmaceutical innovators seeking safer, more effective formulations.
